Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome

Background and Objectives: Myocardial ischemia is the leading cause of mortality and morbidity in all over the world. Previous studies demonstrated that myocardial ischemic patients subjected to coronary angiograph were more likely to have significant high serum proBNP.  This study aimed to assess...

Full description

Bibliographic Details
Main Author: Adil Hassan Alhusseiny
Format: Article
Language:English
Published: College of medicine/ University of Diyala 2019-11-01
Series:Diyala Journal of Medicine
Subjects:
Online Access:http://djm.uodiyala.edu.iq/index.php/djm/article/view/397
_version_ 1797454751213813760
author Adil Hassan Alhusseiny
author_facet Adil Hassan Alhusseiny
author_sort Adil Hassan Alhusseiny
collection DOAJ
description Background and Objectives: Myocardial ischemia is the leading cause of mortality and morbidity in all over the world. Previous studies demonstrated that myocardial ischemic patients subjected to coronary angiograph were more likely to have significant high serum proBNP.  This study aimed to assess the level of serum proBNP levels in myocardial ischemia patients who underwent coronary angiography and to relate the proBNP levels to the severity of coronary artery disease and the components of metabolic syndrome. Methods: A total number of 128 patients admitted to the coronary angiography unit at Diyala Teaching Hospital in Diyala were recruited in the study. Indications of coronary angiography included; acute coronary syndrome, positive treadmill test, stable coronary artery disease and percutaneous coronary intervention. The severity of coronary artery disease was assessed by detecting the significant obstructed lesions in the number of obstructed vessels. Serum proBNP levels were measured after angiography. Results: The results showed non-significant differences in the characteristics of patients and fasting serum lipids in different categories of vessels obstructed. Significant high serum proBNP levels were observed with increasing number of vessels obstructed and weren't related to the existence metabolic syndrome components.  Serum proBNP levels were significantly and inversely correlated (r =0.5, p < 0.001) with ejection fraction of left ventricle. Conclusions: Serum proBNP levels in myocardial ischemia patients are related directly to the severity of coronary artery diseases and inversely to the pumping function of the heart. Metabolic factors are not involved in significant high serum proBNP levels in myocardial ischemia patients
first_indexed 2024-03-09T15:42:38Z
format Article
id doaj.art-2f5ce7f91fe74872af7475b58cbb67f2
institution Directory Open Access Journal
issn 2219-9764
2617-8982
language English
last_indexed 2024-03-09T15:42:38Z
publishDate 2019-11-01
publisher College of medicine/ University of Diyala
record_format Article
series Diyala Journal of Medicine
spelling doaj.art-2f5ce7f91fe74872af7475b58cbb67f22023-11-24T23:23:42ZengCollege of medicine/ University of DiyalaDiyala Journal of Medicine2219-97642617-89822019-11-0151Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic SyndromeAdil Hassan Alhusseiny Background and Objectives: Myocardial ischemia is the leading cause of mortality and morbidity in all over the world. Previous studies demonstrated that myocardial ischemic patients subjected to coronary angiograph were more likely to have significant high serum proBNP.  This study aimed to assess the level of serum proBNP levels in myocardial ischemia patients who underwent coronary angiography and to relate the proBNP levels to the severity of coronary artery disease and the components of metabolic syndrome. Methods: A total number of 128 patients admitted to the coronary angiography unit at Diyala Teaching Hospital in Diyala were recruited in the study. Indications of coronary angiography included; acute coronary syndrome, positive treadmill test, stable coronary artery disease and percutaneous coronary intervention. The severity of coronary artery disease was assessed by detecting the significant obstructed lesions in the number of obstructed vessels. Serum proBNP levels were measured after angiography. Results: The results showed non-significant differences in the characteristics of patients and fasting serum lipids in different categories of vessels obstructed. Significant high serum proBNP levels were observed with increasing number of vessels obstructed and weren't related to the existence metabolic syndrome components.  Serum proBNP levels were significantly and inversely correlated (r =0.5, p < 0.001) with ejection fraction of left ventricle. Conclusions: Serum proBNP levels in myocardial ischemia patients are related directly to the severity of coronary artery diseases and inversely to the pumping function of the heart. Metabolic factors are not involved in significant high serum proBNP levels in myocardial ischemia patients http://djm.uodiyala.edu.iq/index.php/djm/article/view/397Pro brain natriuretic peptide, coronary artery disease, metabolic syndrome
spellingShingle Adil Hassan Alhusseiny
Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome
Diyala Journal of Medicine
Pro brain natriuretic peptide, coronary artery disease, metabolic syndrome
title Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome
title_full Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome
title_fullStr Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome
title_full_unstemmed Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome
title_short Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome
title_sort serum probnp associated with the severity of coronary artery disease its limitation in metabolic syndrome
topic Pro brain natriuretic peptide, coronary artery disease, metabolic syndrome
url http://djm.uodiyala.edu.iq/index.php/djm/article/view/397
work_keys_str_mv AT adilhassanalhusseiny serumprobnpassociatedwiththeseverityofcoronaryarterydiseaseitslimitationinmetabolicsyndrome